D. Boral Capital Reiterates Buy Rating for Anavex Life Sciences (NASDAQ:AVXL)
D. Boral Capital restated their buy rating on shares of Anavex Life Sciences (NASDAQ:AVXL – Free Report) in a research report sent to investors on Monday morning,Benzinga reports. The firm currently has a $46.00 price objective on the biotechnology company’s stock. Separately, HC Wainwright restated a “buy” rating and issued a $40.00 target price on […]
More Stories
POET Technologies (CVE:PTK) Stock Price Up 18.1% – Here’s Why
POET Technologies Inc. (CVE:PTK – Get Free Report) was up 18.1% during trading on Wednesday . The stock traded as...
EnerSys (NYSE:ENS) Releases FY 2025 Earnings Guidance
EnerSys (NYSE:ENS – Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share...
Polaris (NYSE:PII) Reaches New 12-Month Low – What’s Next?
Polaris Inc. (NYSE:PII – Get Free Report)’s share price hit a new 52-week low on Wednesday . The company traded...
Cheniere Energy Partners (NYSE:CQP) and Cheniere Energy (NYSE:LNG) Head to Head Review
Cheniere Energy Partners (NYSE:CQP – Get Free Report) and Cheniere Energy (NYSE:LNG – Get Free Report) are both large-cap oils/energy...
Cloudflare, Inc. (NYSE:NET) Receives Consensus Recommendation of “Hold” from Analysts
Shares of Cloudflare, Inc. (NYSE:NET – Get Free Report) have been assigned an average rating of “Hold” from the twenty-eight...
Deere & Company (NYSE:DE) Receives Average Rating of “Hold” from Brokerages
Deere & Company (NYSE:DE – Get Free Report) has been assigned a consensus rating of “Hold” from the twenty-two analysts...